Temat: "arterial hypertension" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Hemodynamic and Clinical Profiles of Pulmonary Arterial Hypertension Patients with GDF2 and BMPR2 Variants.
Autorzy:: Wang MT; Institute of Emergency and Critical Care Medicine, National Yang Ming Chiao Tung University, Taipei 112, Taiwan.; Department of Critical Care Medicine, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan.
Weng KP; Congenital Structural Heart Disease Center, Department of Pediatrics, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan.
Chang SK; Excelsior Biopharma Inc., Taipei 115, Taiwan.
Huang WC; Department of Critical Care Medicine, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan.; Department of Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei 112, Taiwan.; Department of Physical Therapy, Fooyin University, Kaohsiung 813, Taiwan.
Chen LW; Institute of Emergency and Critical Care Medicine, National Yang Ming Chiao Tung University, Taipei 112, Taiwan.; Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan.; Department of Biological Sciences, National Sun Yat-Sen University, Kaohsiung 813, Taiwan.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 27; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:: Journal Article
MeSH Terms:: Pulmonary Arterial Hypertension*/genetics
Humans ; Familial Primary Pulmonary Hypertension/genetics ; Mutation, Missense ; Hemodynamics ; Sequence Deletion ; Bone Morphogenetic Protein Receptors, Type II/genetics ; Mutation ; Adenosine Triphosphatases/genetics ; Membrane Transport Proteins/genetics ; Growth Differentiation Factor 2/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Diabetes mellitus, glycemic traits, SGLT2 inhibition, and risk of pulmonary arterial hypertension: A Mendelian randomization study.
Autorzy:: Tan JS; Emergency and Critical Care Center, Fuwai Hospital, National Center for Cardiovascular Diseases of China, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yang Y; Emergency and Critical Care Center, Fuwai Hospital, National Center for Cardiovascular Diseases of China, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wang J; Emergency and Critical Care Center, Fuwai Hospital, National Center for Cardiovascular Diseases of China, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wang Y; Emergency and Critical Care Center, Fuwai Hospital, National Center for Cardiovascular Diseases of China, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Lv T; Key Laboratory of Pulmonary Vascular Medicine, Fuwai Hospital, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Shu Y; Emergency and Critical Care Center, Fuwai Hospital, National Center for Cardiovascular Diseases of China, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xu W; Emergency and Critical Care Center, Fuwai Hospital, National Center for Cardiovascular Diseases of China, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Chong L; Key Laboratory of Pulmonary Vascular Medicine, Fuwai Hospital, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Pokaż więcej
Źródło:: Bioscience trends [Biosci Trends] 2024 Mar 19; Vol. 18 (1), pp. 94-104. Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:: Journal Article
MeSH Terms:: Diabetes Mellitus, Type 2*/genetics
Diabetes Mellitus, Type 2*/complications
Pulmonary Arterial Hypertension*/complications
Humans ; Blood Glucose ; Mendelian Randomization Analysis ; Sodium-Glucose Transporter 2/genetics ; Sodium-Glucose Transporter 2/therapeutic use ; Glycated Hemoglobin ; Polymorphism, Single Nucleotide

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: A novel complement C3 inhibitor CP40-KK protects against experimental pulmonary arterial hypertension via an inflammasome NLRP3 associated pathway.
Autorzy:: Dai L; Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.; Hubei Provincial Engineering Research Center of Vascular Interventional Therapy, Wuhan, 430030, Hubei, China.
Chen Y; Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.; Hubei Provincial Engineering Research Center of Vascular Interventional Therapy, Wuhan, 430030, Hubei, China.
Wu J; Department of Gastroenterology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530000, Guangxi, China.
He Z; Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.; Hubei Provincial Engineering Research Center of Vascular Interventional Therapy, Wuhan, 430030, Hubei, China.
Zhang Y; Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.; Hubei Provincial Engineering Research Center of Vascular Interventional Therapy, Wuhan, 430030, Hubei, China.
Zhang W; Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.; Hubei Provincial Engineering Research Center of Vascular Interventional Therapy, Wuhan, 430030, Hubei, China.
Xie Y; Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.; Hubei Provincial Engineering Research Center of Vascular Interventional Therapy, Wuhan, 430030, Hubei, China.
Zeng H; Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. .; Hubei Provincial Engineering Research Center of Vascular Interventional Therapy, Wuhan, 430030, Hubei, China. .
Zhong X; Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. .; Hubei Provincial Engineering Research Center of Vascular Interventional Therapy, Wuhan, 430030, Hubei, China. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2024 Feb 16; Vol. 22 (1), pp. 164. Date of Electronic Publication: 2024 Feb 16.
Typ publikacji:: Journal Article
MeSH Terms:: Hypertension, Pulmonary*
Pulmonary Arterial Hypertension*/drug therapy
Rats ; Humans ; Animals ; Inflammasomes/metabolism ; Interleukin-18/metabolism ; NLR Family, Pyrin Domain-Containing 3 Protein/metabolism ; Complement C3/metabolism ; Complement Inactivating Agents/adverse effects ; Complement Inactivating Agents/metabolism ; Pulmonary Artery/metabolism ; Cytokines/metabolism ; Disease Models, Animal

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: The siRNA-mediated knockdown of AP-1 restores the function of the pulmonary artery and the right ventricle by reducing perivascular and interstitial fibrosis and key molecular players in cardiopulmonary disease.
Autorzy:: Comarița IK; Institute of Cellular Biology and Pathology 'Nicolae Simionescu' of Romanian Academy, Bucharest, Romania.
Tanko G; Institute of Cellular Biology and Pathology 'Nicolae Simionescu' of Romanian Academy, Bucharest, Romania.
Anghelache IL; 'Victor Babeș' National Institute of Pathology, Bucharest, Romania.
Georgescu A; Institute of Cellular Biology and Pathology 'Nicolae Simionescu' of Romanian Academy, Bucharest, Romania. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2024 Feb 05; Vol. 22 (1), pp. 137. Date of Electronic Publication: 2024 Feb 05.
Typ publikacji:: Journal Article
MeSH Terms:: Pulmonary Arterial Hypertension*/pathology
MicroRNAs*/metabolism
Rats ; Animals ; Pulmonary Artery/pathology ; Fibronectins ; Transcription Factor AP-1/metabolism ; Heart Ventricles/pathology ; RNA, Small Interfering/metabolism ; Rats, Sprague-Dawley ; Fibrosis ; Disease Models, Animal

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Right ventricular-pulmonary arterial coupling ratio derived from 3-dimensional echocardiography predicts outcomes in systemic lupus erythematosus-associated pulmonary arterial hypertension patients.
Autorzy:: Lan WF; Department of Ultrasound, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Deng Y; Department of Ultrasound, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Dai P; Department of Ultrasound, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Wu DD; Department of Ultrasound, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Hu J; Department of Ultrasound, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Liao J; Department of Ultrasound, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Meng H; Department of Ultrasound, First Affiliated Hospital of Guangxi Medical University, Nanning, China.; Pokaż więcej
Źródło:: Lupus [Lupus] 2024 Feb; Vol. 33 (2), pp. 155-165. Date of Electronic Publication: 2024 Jan 05.
Typ publikacji:: Journal Article
MeSH Terms:: Pulmonary Arterial Hypertension*
Hypertension, Pulmonary*/etiology
Lupus Erythematosus, Systemic*/complications
Echocardiography, Three-Dimensional*/methods
Ventricular Dysfunction, Right*/etiology
Humans ; Echocardiography

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Connexin43, A Promising Target to Reduce Cardiac Arrhythmia Burden in Pulmonary Arterial Hypertension.
Autorzy:: Sykora M; Centre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, 84104 Bratislava, Slovakia.
Szeiffova Bacova B; Centre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, 84104 Bratislava, Slovakia.
Andelova K; Centre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, 84104 Bratislava, Slovakia.
Egan Benova T; Centre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, 84104 Bratislava, Slovakia.
Martiskova A; Centre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, 84104 Bratislava, Slovakia.
Kurahara LH; Department of Cardiovascular Physiology, Faculty of Medicine, Kagawa University, Takamatsu 761-0793, Japan.
Hirano K; Department of Cardiovascular Physiology, Faculty of Medicine, Kagawa University, Takamatsu 761-0793, Japan.
Tribulova N; Centre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, 84104 Bratislava, Slovakia.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 14; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Pulmonary Arterial Hypertension*/drug therapy
Hypertension*/drug therapy
Heart Failure*/drug therapy
Humans ; Connexin 43/metabolism ; Arrhythmias, Cardiac/drug therapy ; Arrhythmias, Cardiac/etiology ; Anti-Arrhythmia Agents/pharmacology ; Anti-Arrhythmia Agents/therapeutic use ; Cardiac Conduction System Disease ; Familial Primary Pulmonary Hypertension/complications ; Inflammation/drug therapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Canagliflozin ameliorates hypobaric hypoxia-induced pulmonary arterial hypertension by inhibiting pulmonary arterial smooth muscle cell proliferation.
Autorzy:: Tang L; Department of Cardiovascular Medicine, The General Hospital of Western Theater Command PLA, Chengdu, China.
Cai Q; Department of Cardiology, Fujian Medical Center for Cardiovascular Diseases, Fujian Institute of Coronary Heart Disease, Fujian Medical University Union Hospital, Fuzhou, China.
Wang X; Department of Cardiovascular Medicine, The General Hospital of Western Theater Command PLA, Chengdu, China.
Li X; Department of Cardiovascular Medicine, The General Hospital of Western Theater Command PLA, Chengdu, China.
Li X; Department of Cardiovascular Medicine, The General Hospital of Western Theater Command PLA, Chengdu, China.
Chen L; Department of Cardiology, Fujian Medical Center for Cardiovascular Diseases, Fujian Institute of Coronary Heart Disease, Fujian Medical University Union Hospital, Fuzhou, China.
Yang Y; Department of Cardiovascular Medicine, The General Hospital of Western Theater Command PLA, Chengdu, China.; Pokaż więcej
Źródło:: Clinical and experimental hypertension (New York, N.Y. : 1993) [Clin Exp Hypertens] 2023 Dec 31; Vol. 45 (1), pp. 2278205. Date of Electronic Publication: 2023 Nov 16.
Typ publikacji:: Journal Article
MeSH Terms:: Pulmonary Arterial Hypertension*/drug therapy
Pulmonary Arterial Hypertension*/etiology
Pulmonary Arterial Hypertension*/metabolism
Hypertension, Pulmonary*/drug therapy
Hypertension, Pulmonary*/etiology
Hypertension, Pulmonary*/metabolism
Humans ; Mice ; Animals ; Canagliflozin/adverse effects ; Pulmonary Artery ; Hypoxia/complications ; Hypoxia/metabolism ; Myocytes, Smooth Muscle/metabolism ; Cell Proliferation ; Glucose/pharmacology ; Vascular Remodeling ; Monocrotaline/pharmacology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Impact of selexipag use within 12 months of pulmonary arterial hypertension diagnosis on hospitalizations and medical costs: A retrospective cohort study.
Autorzy:: Tsang Y; Real-World Value & Evidence, Janssen Scientific Affairs, LLC, Titusville, New Jersey, USA.
Stokes M; Data Analytics, Evidera, St-Laurent, Quebec, Canada.
Kim YJ; Data Analytics, Evidera, St-Laurent, Quebec, Canada.
Tilney R; Data Analytics, Evidera, Waltham, Massachusetts, USA.
Panjabi S; Real-World Value & Evidence, Janssen Scientific Affairs, LLC, Titusville, New Jersey, USA.; Pokaż więcej
Źródło:: The clinical respiratory journal [Clin Respir J] 2023 Dec; Vol. 17 (12), pp. 1209-1222. Date of Electronic Publication: 2023 Oct 07.
Typ publikacji:: Journal Article
MeSH Terms:: Pulmonary Arterial Hypertension*/diagnosis
Pulmonary Arterial Hypertension*/drug therapy
Hypertension, Pulmonary*/diagnosis
Hypertension, Pulmonary*/drug therapy
Hypertension, Pulmonary*/metabolism
Humans ; Antihypertensive Agents/therapeutic use ; Retrospective Studies ; Familial Primary Pulmonary Hypertension ; Hospitalization ; Disease Progression

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Establishment of a canine model of pulmonary arterial hypertension induced by dehydromonocrotaline and ultrasonographic study of right ventricular remodeling.
Autorzy:: Dong J; Department of Cardiovascular Ultrasound, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu Province, China.
Jiang XM; Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu Province, China.
Xie DJ; Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu Province, China.
Luo J; Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu Province, China.
Ran H; Department of Cardiovascular Ultrasound, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu Province, China.
Li L; Department of Cardiovascular Ultrasound, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu Province, China.
Li M; Department of Cardiovascular Ultrasound, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu Province, China.
Jiang P; Department of Cardiovascular Ultrasound, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu Province, China.
Zhang PY; Department of Cardiovascular Ultrasound, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu Province, China.
Zhou L; Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu Province, China.; Pokaż więcej
Źródło:: Clinical and experimental hypertension (New York, N.Y. : 1993) [Clin Exp Hypertens] 2023 Dec 31; Vol. 45 (1), pp. 2190503.
Typ publikacji:: Journal Article
MeSH Terms:: Pulmonary Arterial Hypertension*
Hypertension, Pulmonary*/diagnostic imaging
Hypertension, Pulmonary*/etiology
Ventricular Dysfunction, Right*
Dogs ; Animals ; Ventricular Remodeling ; Dimethylformamide ; Hypertrophy, Right Ventricular/diagnostic imaging ; Hypertrophy, Right Ventricular/etiology ; Ventricular Function, Right

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Modulating NO-GC Pathway in Pulmonary Arterial Hypertension.
Autorzy:: D'Agostino A; IRCCS SYNLAB SDN, Via Emanuele Gianturco 113, 80143 Naples, Italy.
Lanzafame LG; Department of Clinical and Experimental Medicine, Internal Medicine, Garibaldi Hospital, University of Catania, Via Palermo 636, 95122 Catania, Italy.; Department of Translational Medical Sciences, 'Federico II' University of Naples, Via Pansini 5, 80131 Naples, Italy.
Buono L; IRCCS SYNLAB SDN, Via Emanuele Gianturco 113, 80143 Naples, Italy.
Crisci G; Department of Translational Medical Sciences, 'Federico II' University of Naples, Via Pansini 5, 80131 Naples, Italy.
D'Assante R; Department of Translational Medical Sciences, 'Federico II' University of Naples, Via Pansini 5, 80131 Naples, Italy.
Leone I; IRCCS SYNLAB SDN, Via Emanuele Gianturco 113, 80143 Naples, Italy.
De Vito L; Department of Translational Medical Sciences, 'Federico II' University of Naples, Via Pansini 5, 80131 Naples, Italy.
Bossone E; Department of Public Health, 'Federico II' University of Naples, Via Pansini 5, 80131 Naples, Italy.
Cittadini A; Department of Translational Medical Sciences, 'Federico II' University of Naples, Via Pansini 5, 80131 Naples, Italy.; Gender Interdipartimental Institute of Research (GENESIS), 'Federico II' University of Naples, Via Pansini 5, 80131 Naples, Italy.
Marra AM; Department of Translational Medical Sciences, 'Federico II' University of Naples, Via Pansini 5, 80131 Naples, Italy.; Gender Interdipartimental Institute of Research (GENESIS), 'Federico II' University of Naples, Via Pansini 5, 80131 Naples, Italy.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Dec 19; Vol. 25 (1). Date of Electronic Publication: 2023 Dec 19.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Pulmonary Arterial Hypertension*/drug therapy
Humans ; Nitric Oxide ; Familial Primary Pulmonary Hypertension ; Phosphodiesterase 5 Inhibitors/pharmacology ; Phosphodiesterase 5 Inhibitors/therapeutic use ; Sildenafil Citrate/pharmacology ; Sildenafil Citrate/therapeutic use ; Soluble Guanylyl Cyclase

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Angiotensin-Converting Enzyme 2 (ACE2) Signaling in Pulmonary Arterial Hypertension: Underpinning Mechanisms and Potential Targeting Strategies.
Autorzy:: Papavassiliou KA; First University Department of Respiratory Medicine, 'Sotiria' Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Gogou VA; First University Department of Respiratory Medicine, 'Sotiria' Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Papavassiliou AG; Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Dec 13; Vol. 24 (24). Date of Electronic Publication: 2023 Dec 13.
Typ publikacji:: Journal Article
MeSH Terms:: Pulmonary Arterial Hypertension*
Hypertension, Pulmonary*/drug therapy
Humans ; Angiotensin-Converting Enzyme 2/therapeutic use ; Peptidyl-Dipeptidase A/metabolism ; Familial Primary Pulmonary Hypertension ; Receptors, G-Protein-Coupled/metabolism ; Angiotensin I/metabolism ; Peptide Fragments/metabolism ; Renin-Angiotensin System

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Pathophysiology and Treatment of Pulmonary Arterial Hypertension.
Autorzy:: Fukumoto Y; Division of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Jan 18; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 18.
Typ publikacji:: Editorial
MeSH Terms:: Pulmonary Arterial Hypertension*/therapy
Hypertension, Pulmonary*/therapy
Humans ; Familial Primary Pulmonary Hypertension

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: CDN1163 alleviates SERCA2 dysfunction-induced pulmonary vascular remodeling by inhibiting the phenotypic transition of pulmonary artery smooth muscle cells.
Autorzy:: Yu W; Institute of Health Biological Chemical Medication, Chongqing Institute of Green and Intelligent Technology, Chinese Academy of Sciences, Chongqing, China.; School of Pharmaceutical Sciences, Chongqing University, Chongqing, China.
Zhang Q; School of Pharmaceutical Sciences, Chongqing University, Chongqing, China.
Qiu Y; School of Pharmaceutical Sciences, Chongqing University, Chongqing, China.
Chen H; School of Pharmaceutical Sciences, Chongqing University, Chongqing, China.
Huang X; School of Pharmaceutical Sciences, Chongqing University, Chongqing, China.
Xiao L; School of Pharmaceutical Sciences, Chongqing University, Chongqing, China.
Xu G; Institute of Medicine and Equipment for High Altitude Region, College of High Altitude Military Medicine, Army Medical University (Third Military Medical University), Chongqing, China.; Key Laboratory of High Altitude Medicine, People's Liberation Army, Chongqing, China.
Li S; School of Pharmaceutical Sciences, Chongqing University, Chongqing, China.; Central Clinical School, Monash University, Melbourne, Australia.
Hu P; College of Pharmacy, Chongqing Medical University, Chongqing, China.
Tong X; School of Pharmaceutical Sciences, Chongqing University, Chongqing, China.; Jinfeng Laboratory, Chongqing, China.; Pokaż więcej
Źródło:: Clinical and experimental hypertension (New York, N.Y. : 1993) [Clin Exp Hypertens] 2023 Dec 31; Vol. 45 (1), pp. 2272062. Date of Electronic Publication: 2023 Oct 29.
Typ publikacji:: Journal Article
MeSH Terms:: Hypertension, Pulmonary*
Pulmonary Arterial Hypertension*/metabolism
Mice ; Humans ; Animals ; Pulmonary Artery ; Endoribonucleases/metabolism ; Vascular Remodeling ; Protein Serine-Threonine Kinases/metabolism ; Cell Proliferation ; Myocytes, Smooth Muscle/metabolism ; Cells, Cultured

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Correlation between pulmonary vascular performance and hemodynamics in patients with pulmonary arterial hypertension.
Autorzy:: Yasenjiang M; Xinjiang Medical University, Urumqi, China.
Cheng H; Department of Cardiology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.
Guo Z; Department of Cardiology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.
Yu X; Department of Cardiology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.
Adilijiang T; Department of Cardiology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.
Li G; Department of Cardiology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.; Pokaż więcej
Źródło:: Clinical and experimental hypertension (New York, N.Y. : 1993) [Clin Exp Hypertens] 2023 Dec 31; Vol. 45 (1), pp. 2185253.
Typ publikacji:: Journal Article
MeSH Terms:: Pulmonary Arterial Hypertension*
Hypertension, Pulmonary*
Humans ; Hemodynamics ; Pulmonary Artery ; Lung

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Mendelian randomization study on causal association of IL-6 signaling with pulmonary arterial hypertension.
Autorzy:: Zhang M; Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Capital Medical University, China.
Zeng Q; Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Capital Medical University, China.
Zhou S; Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Capital Medical University, China.
Zhu G; Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Capital Medical University, China.
Xu Y; Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Capital Medical University, China.
Gao R; Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Capital Medical University, China.
Su W; Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Capital Medical University, China.
Wang R; Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Capital Medical University, China.; Pokaż więcej
Źródło:: Clinical and experimental hypertension (New York, N.Y. : 1993) [Clin Exp Hypertens] 2023 Dec 31; Vol. 45 (1), pp. 2183963.
Typ publikacji:: Journal Article
MeSH Terms:: Pulmonary Arterial Hypertension*
Humans ; Interleukin-6 ; Genome-Wide Association Study ; Mendelian Randomization Analysis ; Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: IL-1β-mediated adaptive reprogramming of endogenous human cardiac fibroblasts to cells with immune features during fibrotic remodeling.
Autorzy:: Siamwala JH; Department of Molecular Pharmacology, Physiology and Biotechnology, Brown University, Providence, RI, USA. .; Warren Alpert Medical School of Brown University, Providence VA Medical Center, Providence, RI, USA. .
Pagano FS; Department of Molecular Pharmacology, Physiology and Biotechnology, Brown University, Providence, RI, USA.
Dubielecka PM; Division of Hematology/Oncology, Department of Medicine, Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence, RI, USA.
Ivey MJ; Department of Pathology & Laboratory Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH, USA.
Guirao-Abad JP; Department of Pathology & Laboratory Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH, USA.
Zhao A; Department of Molecular Pharmacology, Physiology and Biotechnology, Brown University, Providence, RI, USA.
Chen S; Warren Alpert Medical School of Brown University, Providence VA Medical Center, Providence, RI, USA.; Department of Pathology & Laboratory Medicine, Rhode Island Hospital, Providence, RI, USA.
Granston H; Department of Molecular Pharmacology, Physiology and Biotechnology, Brown University, Providence, RI, USA.
Jeong JY; Department of Molecular Pharmacology, Physiology and Biotechnology, Brown University, Providence, RI, USA.
Rounds S; Warren Alpert Medical School of Brown University, Providence VA Medical Center, Providence, RI, USA.; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Warren Alpert Medical School of Brown University, Providence, RI, USA.
Kanisicak O; Department of Pathology & Laboratory Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH, USA.
Sadayappan S; Heart, Lung and Vascular Institute, Division of Cardiovascular Health and Disease, Department of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH, USA.
Gilbert RJ; Ocean State Research Institute, Providence VA Medical Center, Providence, RI, USA.; Pokaż więcej
Źródło:: Communications biology [Commun Biol] 2023 Nov 25; Vol. 6 (1), pp. 1200. Date of Electronic Publication: 2023 Nov 25.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Heart*
Pulmonary Arterial Hypertension*
Animals ; Humans ; Mice ; Rats ; Fibroblasts/metabolism ; Fibrosis ; Myofibroblasts/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Proteomic biomarkers for survival in systemic sclerosis-associated pulmonary hypertension.
Autorzy:: Mismetti V; Université Jean Monnet Saint-Étienne, Mines Saint-Etienne, INSERM, SAINBIOSE U1059, 42023, Saint-Etienne, France.
Delavenne X; Université Jean Monnet Saint-Étienne, Mines Saint-Etienne, INSERM, SAINBIOSE U1059, 42023, Saint-Etienne, France.
Montani D; Service de Pneumologie et Soins Intensifs Thoraciques, Centre de Référence de L'Hypertension Pulmonaire, INSERM U999 Centre de Compétence Maladies Pulmonaires Rares-OrphaLung Hôpital de Bicêtre, Le Kremlin Bicêtre, Paris, France.
Bezzeghoud S; Service de Médecine Vasculaire et Thérapeutique, INSERM, CIC-1408, CHU de Saint-Etienne, Saint-Etienne, France.
Delezay O; Université Jean Monnet Saint-Étienne, Mines Saint-Etienne, INSERM, SAINBIOSE U1059, 42023, Saint-Etienne, France.
Hodin S; Université Jean Monnet Saint-Étienne, Mines Saint-Etienne, INSERM, SAINBIOSE U1059, 42023, Saint-Etienne, France.
Launay D; Service de Médecine Interne et d'Immunologie Clinique, Centre de Référence des Maladies Auto-Immunes et Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO) CHU Lille, Lille, France.
Marchand-Adam S; Service de Pneumologie et Explorations Fonctionnaires Respiratoires, Tours, France.
Nunes H; Service de Pneumologie, Centre de Référence des Maladies Pulmonaires Rares, Hôpital Avicenne, INSERM U1272, Université Sorbonne Paris Nord, Bobigny, France.
Ollier E; Université Jean Monnet Saint-Étienne, Mines Saint-Etienne, INSERM, SAINBIOSE U1059, 42023, Saint-Etienne, France.
Reynaud-Gaubert M; Centre de Compétence des Maladies Pulmonaires Rares (OrphaLung), Service de Pneumologie et Transplantation Pulmonaire, CHU Nord, AP-HM, Aix Marseille Université, Marseille, France.
Pastre J; Service de Pneumologie et Soins Intensifs Centre de Compétence Maladie Pulmonaire Rare (OrphaLung) Hôpital Européen Georges Pompidou, AP-HP, Paris, France.
Traclet J; National Reference Center for Rare Pulmonary Diseases, Department of Respiratory Diseases, Hospices Civils de Lyon, Louis Pradel Hospital, 69677, Lyon, France.
Quetant S; Service de Pneumologie, Grenoble, France.
Zeghmar S; National Reference Center for Rare Pulmonary Diseases, Department of Respiratory Diseases, Hospices Civils de Lyon, Louis Pradel Hospital, 69677, Lyon, France.
Bertoletti L; Service de Médecine Vasculaire et Thérapeutique, INSERM, UMR1059, Université Jean-Monnet, INSERM, CIC-1408, CHU de Saint-Etienne, INNOVTE, 42055, Saint-Etienne, France. .
Cottin V; National Reference Center for Rare Pulmonary Diseases, Department of Respiratory Diseases, Hospices Civils de Lyon, Louis Pradel Hospital, 69677, Lyon, France.; Univ Lyon, INRA, UMR754, 69008, Lyon, France.; Pokaż więcej
Źródło:: Respiratory research [Respir Res] 2023 Nov 07; Vol. 24 (1), pp. 273. Date of Electronic Publication: 2023 Nov 07.
Typ publikacji:: Multicenter Study; Journal Article
MeSH Terms:: Hypertension, Pulmonary*/diagnosis
Hypertension, Pulmonary*/etiology
Scleroderma, Systemic*/complications
Scleroderma, Systemic*/diagnosis
Lung Diseases, Interstitial*
Pulmonary Arterial Hypertension*
Humans ; Prospective Studies ; Proteomics ; Biomarkers ; Fibrosis ; Blood Proteins ; Lung

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Prostaglandin and prostaglandin receptors: present and future promising therapeutic targets for pulmonary arterial hypertension.
Autorzy:: Zeng C; Department of Cardiology, The Second Xiangya Hospital of Central South University, No.139, Middle Ren-min Road, Changsha, 410011, Hunan Province, People's Republic of China.
Liu J; Department of Cardiology, The Second Xiangya Hospital of Central South University, No.139, Middle Ren-min Road, Changsha, 410011, Hunan Province, People's Republic of China.
Zheng X; Department of Cardiology, The Second Xiangya Hospital of Central South University, No.139, Middle Ren-min Road, Changsha, 410011, Hunan Province, People's Republic of China.
Hu X; Department of Cardiology, The Second Xiangya Hospital of Central South University, No.139, Middle Ren-min Road, Changsha, 410011, Hunan Province, People's Republic of China. .
He Y; Department of Cardiology, The Second Xiangya Hospital of Central South University, No.139, Middle Ren-min Road, Changsha, 410011, Hunan Province, People's Republic of China. .; Pokaż więcej
Źródło:: Respiratory research [Respir Res] 2023 Nov 01; Vol. 24 (1), pp. 263. Date of Electronic Publication: 2023 Nov 01.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Prostaglandins*
Pulmonary Arterial Hypertension*/drug therapy
Humans ; Receptors, Prostaglandin ; Vascular Remodeling ; Familial Primary Pulmonary Hypertension ; Epoprostenol/therapeutic use ; Prostaglandins I ; Inflammation/drug therapy ; Pulmonary Artery

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Risk factors of pulmonary arterial hypertension in patients with systemic lupus erythematosus: A meta-analysis.
Autorzy:: Liu Y; Beijing Luhe Hospital, Capital Medical University, Beijing, China.
Cheng Z; Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Zha B; Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Chen X; Beijing Luhe Hospital, Capital Medical University, Beijing, China.
Gong Z; Beijing Luhe Hospital, Capital Medical University, Beijing, China.
Ji L; Central Laboratory, Beijing Luhe Clinical Institute, Capital Medical University, Beijing, China.
Wei L; Beijing Key Laboratory of Diabetic Prevention and Research, Center for Endocrine Metabolism and Immune Diseases, Beijing Luhe Hospital, Capital Medical University, Beijing, China.; Pokaż więcej
Źródło:: Lupus [Lupus] 2023 Oct; Vol. 32 (11), pp. 1310-1319. Date of Electronic Publication: 2023 Sep 12.
Typ publikacji:: Meta-Analysis; Journal Article
MeSH Terms:: Pulmonary Arterial Hypertension*/epidemiology
Pulmonary Arterial Hypertension*/etiology
Hypertension, Pulmonary*/epidemiology
Hypertension, Pulmonary*/etiology
Hypertension, Pulmonary*/diagnosis
Lupus Erythematosus, Systemic*/complications
Lupus Erythematosus, Systemic*/epidemiology
Lupus Erythematosus, Systemic*/diagnosis
Humans ; Female ; Risk Factors ; Prognosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Predictors of the response to phosphodiesterase-5 inhibitors in pulmonary arterial hypertension: an analysis of the Spanish registry.
Autorzy:: Garcia AR; Department of Pulmonary Medicine, Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain.; Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain.
Blanco I; Department of Pulmonary Medicine, Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain.; Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain.
Ramon L; Department of Pulmonary Medicine, Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain.; Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain.
Pérez-Sagredo J; Department of Pulmonary Medicine, Hospital El Bierzo, León, Spain.
Guerra-Ramos FJ; Department of Pulmonary Medicine, Complejo Hospitalario Universitario Insular-Materno Infantil, Las Palmas, Spain.
Martín-Ontiyuelo C; Department of Pulmonary Medicine, Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain.; Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain.
Tura-Ceide O; Department of Pulmonary Medicine, Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain.; Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain.
Pastor-Pérez F; Cardiology Department, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
Escribano-Subías P; Pulmonary Hypertension Unit, Cardiology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.; Biomedical Research Networking Center on Cardiovascular Diseases (CIBERCV), Madrid, Spain.
Barberà JA; Department of Pulmonary Medicine, Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain. .; Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain. .; Pokaż więcej
Źródło:: Respiratory research [Respir Res] 2023 Sep 15; Vol. 24 (1), pp. 223. Date of Electronic Publication: 2023 Sep 15.
Typ publikacji:: Journal Article
MeSH Terms:: Pulmonary Arterial Hypertension*/diagnosis
Pulmonary Arterial Hypertension*/drug therapy
Pulmonary Arterial Hypertension*/epidemiology
HIV Infections*
Humans ; Male ; Cyclic Nucleotide Phosphodiesterases, Type 5 ; Phosphodiesterase 5 Inhibitors/therapeutic use ; Familial Primary Pulmonary Hypertension ; Registries

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 21.

Tytuł:: A prognostic model for systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study.
Autorzy:: Qu J; Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, State Key Laboratory of Complex Severe and Rare Diseases, Ministry of Science and Technology, No. 1 Shuaifuyuan, Wangfujing Ave, Beijing, 100730, China.; Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, China.
Li M; Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, State Key Laboratory of Complex Severe and Rare Diseases, Ministry of Science and Technology, No. 1 Shuaifuyuan, Wangfujing Ave, Beijing, 100730, China. .
Zhang X; Department of Rheumatology, Guangdong General Hospital, Guangzhou, China.
Zhang M; Department of Rheumatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Zuo X; Department of Rheumatology, Xiangya Hospital, Central South University, Changsha, China.
Zhu P; Department of Clinical Immunology, PLA Specialized Research Institute of Rheumatology and Immunology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Ye S; Department of Rheumatology, School of Medicine, Shanghai Jiao Tong University, Ren Ji Hospital South Campus, Shanghai, China.
Zhang W; Department of Rheumatology, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, Shanghai, China.
Zheng Y; Department of Rheumatology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Qi W; Department of Rheumatology, The First Central Hospital, Tianjin, China.
Li Y; Department of Rheumatology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Zhang Z; Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing, China.
Ding F; Department of Rheumatology, Qilu Hospital of Shandong University, Jinan, China.
Gu J; Department of Rheumatology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Liu Y; Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China.
Qian J; Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, State Key Laboratory of Complex Severe and Rare Diseases, Ministry of Science and Technology, No. 1 Shuaifuyuan, Wangfujing Ave, Beijing, 100730, China.
Huang C; Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, State Key Laboratory of Complex Severe and Rare Diseases, Ministry of Science and Technology, No. 1 Shuaifuyuan, Wangfujing Ave, Beijing, 100730, China.
Zhao J; Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, State Key Laboratory of Complex Severe and Rare Diseases, Ministry of Science and Technology, No. 1 Shuaifuyuan, Wangfujing Ave, Beijing, 100730, China.
Wang Q; Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, State Key Laboratory of Complex Severe and Rare Diseases, Ministry of Science and Technology, No. 1 Shuaifuyuan, Wangfujing Ave, Beijing, 100730, China.
Liu Y; Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, State Key Laboratory of Complex Severe and Rare Diseases, Ministry of Science & Technology, Beijing, China.
Tian Z; Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, State Key Laboratory of Complex Severe and Rare Diseases, Ministry of Science & Technology, Beijing, China.
Wang Y; Department of Epidemiology and Bio-Statistics, Institute of Basic Medical Sciences, China Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wei W; Department of Rheumatology, Tianjin Medical University General Hospital, No. 154 Anshan Street, Tianjin, 300052, China. .
Zeng X; Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, State Key Laboratory of Complex Severe and Rare Diseases, Ministry of Science and Technology, No. 1 Shuaifuyuan, Wangfujing Ave, Beijing, 100730, China. .; Pokaż więcej
Źródło:: Respiratory research [Respir Res] 2023 Sep 09; Vol. 24 (1), pp. 220. Date of Electronic Publication: 2023 Sep 09.
Typ publikacji:: Multicenter Study; Journal Article
MeSH Terms:: Pulmonary Arterial Hypertension*/diagnosis
Pulmonary Arterial Hypertension*/epidemiology
Pulmonary Arterial Hypertension*/etiology
Hypertension, Pulmonary*/diagnosis
Hypertension, Pulmonary*/epidemiology
Hypertension, Pulmonary*/etiology
Lupus Erythematosus, Systemic*/complications
Lupus Erythematosus, Systemic*/diagnosis
Lupus Erythematosus, Systemic*/epidemiology
Humans ; Cohort Studies ; Prognosis ; Familial Primary Pulmonary Hypertension

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 22.

Tytuł:: Therapeutic Approaches in Pulmonary Arterial Hypertension with Beneficial Effects on Right Ventricular Function-Preclinical Studies.
Autorzy:: Balsa A; Cardiovascular R&D , Department of Surgery and Physiology, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.
Adão R; Cardiovascular R&D , Department of Surgery and Physiology, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.; Department of Pharmacology and Toxicology, School of Medicine, Complutense University of Madrid, 28040 Madrid, Spain.; CIBER of Respiratory Diseases (CIBERES), 28029 Madrid, Spain.
Brás-Silva C; Cardiovascular R&D , Department of Surgery and Physiology, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.; Faculty of Nutrition and Food Sciences, University of Porto, 4150-180 Porto, Portugal.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Oct 24; Vol. 24 (21). Date of Electronic Publication: 2023 Oct 24.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Pulmonary Arterial Hypertension*/drug therapy
Hypertension, Pulmonary*/drug therapy
Humans ; Mice ; Rats ; Animals ; Ventricular Function, Right ; Pulmonary Artery ; Familial Primary Pulmonary Hypertension ; Disease Models, Animal

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 23.

Tytuł:: Mesenchymal stem cell-derived extracellular vesicles prevent the formation of pulmonary arterial hypertension through a microRNA-200b-dependent mechanism.
Autorzy:: Wan M; Department of Respiratory Emergency and Critical Care, The First Affiliated Hospital of Nanchang University, No. 17, Yongwai Zheng Street, Nanchang, Jiangxi Province, 330006, P. R. China.
Lu C; Department of Respiratory Emergency and Critical Care, The First Affiliated Hospital of Nanchang University, No. 17, Yongwai Zheng Street, Nanchang, Jiangxi Province, 330006, P. R. China.
Liu Y; Department of Respiratory Emergency and Critical Care, The First Affiliated Hospital of Nanchang University, No. 17, Yongwai Zheng Street, Nanchang, Jiangxi Province, 330006, P. R. China.
Luo F; Department of Respiratory Emergency and Critical Care, The First Affiliated Hospital of Nanchang University, No. 17, Yongwai Zheng Street, Nanchang, Jiangxi Province, 330006, P. R. China.
Zhou J; Department of Respiratory Emergency and Critical Care, The First Affiliated Hospital of Nanchang University, No. 17, Yongwai Zheng Street, Nanchang, Jiangxi Province, 330006, P. R. China. .
Xu F; Department of Respiratory Emergency and Critical Care, The First Affiliated Hospital of Nanchang University, No. 17, Yongwai Zheng Street, Nanchang, Jiangxi Province, 330006, P. R. China. .; Pokaż więcej
Źródło:: Respiratory research [Respir Res] 2023 Sep 27; Vol. 24 (1), pp. 233. Date of Electronic Publication: 2023 Sep 27.
Typ publikacji:: Journal Article
MeSH Terms:: Pulmonary Arterial Hypertension*/metabolism
MicroRNAs*/genetics
MicroRNAs*/metabolism
Mesenchymal Stem Cells*/metabolism
Extracellular Vesicles*/metabolism
Humans ; Rats ; Animals ; Familial Primary Pulmonary Hypertension

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 24.

Tytuł:: In the Search for Biomarkers of Pulmonary Arterial Hypertension, Are Cytokines IL-2, IL-4, IL-6, IL-10, and IFN-Gamma the Right Indicators to Use?
Autorzy:: Tomaszewski M; Department of Cardiology, Medical University of Lublin, Jaczewskiego 8, 20-954 Lublin, Poland.
Mertowska P; Department of Experimental Immunology, Medical University of Lublin, Chodzki 4a, 20-093 Lublin, Poland.
Janczewska M; Department of Cardiology, Medical University of Lublin, Jaczewskiego 8, 20-954 Lublin, Poland.
Styczeń A; Department of Cardiology, Medical University of Lublin, Jaczewskiego 8, 20-954 Lublin, Poland.
Mertowski S; Department of Experimental Immunology, Medical University of Lublin, Chodzki 4a, 20-093 Lublin, Poland.
Jonas K; Pulmonary Circulation Centre, Department of Cardiac and Vascular Diseases, Jagiellonian University Medical College, Centre for Rare Cardiovascular Diseases, John Paul II Hospital, ul. Pradnicka 80, 31-202 Krakow, Poland.
Grywalska E; Department of Experimental Immunology, Medical University of Lublin, Chodzki 4a, 20-093 Lublin, Poland.
Kopeć G; Pulmonary Circulation Centre, Department of Cardiac and Vascular Diseases, Jagiellonian University Medical College, Centre for Rare Cardiovascular Diseases, John Paul II Hospital, ul. Pradnicka 80, 31-202 Krakow, Poland.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Sep 05; Vol. 24 (18). Date of Electronic Publication: 2023 Sep 05.
Typ publikacji:: Journal Article
MeSH Terms:: Pulmonary Arterial Hypertension*
Hypertension, Pulmonary*/metabolism
Humans ; Cytokines/metabolism ; Interleukin-10 ; Interleukin-6 ; Interleukin-2 ; Interleukin-4 ; Familial Primary Pulmonary Hypertension ; Interferon-gamma ; Biomarkers

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 25.

Tytuł:: Metabolomics in Pulmonary Hypertension-A Useful Tool to Provide Insights into the Dark Side of a Tricky Pathology.
Autorzy:: Bassareo PP; Mater Misercordiae University Hospital, D07 R2WY Dublin, Ireland.; Children's Health Ireland at Crumlin, D12 N512 Dublin, Ireland.; School of Medicine, University College Dublin, D04 V1W8 Dublin, Ireland.
D'Alto M; Pulmonary Hypertension Unit, Dipartimento di Cardiologia, Università della Campania 'Luigi Vanvitelli', Ospedale Monaldi, 80131 Naples, Italy.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Aug 25; Vol. 24 (17). Date of Electronic Publication: 2023 Aug 25.
Typ publikacji:: Systematic Review; Journal Article; Review
MeSH Terms:: Hypertension, Pulmonary*
Pulmonary Arterial Hypertension*
Body Fluids*
Humans ; Metabolomics ; Familial Primary Pulmonary Hypertension

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""arterial hypertension"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji